{
    "nct_id": "NCT06865768",
    "official_title": "Prospective Phase II Validation of the Performance of a Prostate-Specific Membrane Antigen (PSMA) Radiotracer for Positron Emission Tomography-Multiparametric Magnetic Resonance (PET-mpMR) Imaging to Target Prostate Biopsy Via Transrectal Ultrasound (TRUS) -Magnetic Resonance Imaging (MRI) Fusion Technique",
    "inclusion_criteria": "* Male subjects aged > 18 years\n* Patients with suspected prostate cancer who will have prostate biopsy for confirmation\n* Ability to lie still for MRI scanning\n* Patients must be able to provide written informed consent\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Documented acute prostatitis, symptomatic or severe benign prostatic hyperplasia (BPH) or urinary tract infections\n* Patients with contraindications for MRI including implantable pace makers, cochlear implants\n* Patients with uni- or bilateral hip prosthesis\n* Subjects with other significant medical conditions that would create unacceptable prostate biopsy risk, compromise retention on study or compromise study related assessments\n* Prostate biopsy within 4 weeks prior to entry on this study in which inflammation might affect PET-mpMR result\n* Is determined by the Investigator that the patient is clinically unsuitable for the study\n* Is incapable of understanding the language in which the information for the patient is given\n* Participation in a concurrent clinical trial or in another trial within the past 30 days",
    "miscellaneous_criteria": ""
}